NPPA Requests, Intrathecal baclofen

Shane Le Brun made this Official Information request to Pharmaceutical Management Agency

The request was successful.

From: Shane Le Brun

Dear Pharmaceutical Management Agency,

OIA Request, Intrathecal Baclofen.

I would like to know, if since the beginning of 2010, any NPPA requests have been made for Intrathecal Baclofen, for the treatment of severe spasticity related to MS or other conditions,
and if so, how many have NPPA requests were made, how many were approved, and what costs have been involved with these approved requests, on an annual basis, and averaged out per patient.

Yours faithfully,

Shane Le Brun

Link to this

From: Web Enquiry
Pharmaceutical Management Agency

Dear Shane

 

This email is to acknowledge that your request for information under the
Official Information Act (1982) has been received and is currently being
worked on. We will have a reply to you as soon as possible and no later
than the due date of 7 July.

 

Kind regards

 

 

Victoria London | Communications Adviser

show quoted sections

Link to this

From: Web Enquiry
Pharmaceutical Management Agency


Attachment NPPA requests for Intrathecal Baclofen OIA.pdf
74K Download View as HTML


Dear Shane

Please find attached, PHARMAC's response to your recent OIA request.

Kind regards

Victoria London | Communications Adviser

show quoted sections

Link to this

Things to do with this request

Anyone:
Pharmaceutical Management Agency only: